Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers

Fig. 5

Survival curves for complex ALK fusion subtype and canonical ALK fusion subtype detected by DNA-based NGS. A Survival curves for patients with crizotinib treatment with complex ALK fusions (n = 5) and canonical ALK fusions (n = 34). B Survival curves for patients with crizotinib or alectinib treatment with complex ALK fusions (n = 6) and canonical ALK fusions (n = 36)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us